{"id":"https://openalex.org/W2596637202","doi":"https://doi.org/10.1182/blood.v114.22.2798.2798","title":"A Novel Upregulation of Fanconi Anemia/BRCA DNA Repair Pathway Is Observed Upon Co-Culture of Bone Marrow Stroma with Multiple Myeloma Cell Lines: A Potential New Participant(s) in Environment Mediated Drug Resistance.","display_name":"A Novel Upregulation of Fanconi Anemia/BRCA DNA Repair Pathway Is Observed Upon Co-Culture of Bone Marrow Stroma with Multiple Myeloma Cell Lines: A Potential New Participant(s) in Environment Mediated Drug Resistance.","publication_year":2009,"publication_date":"2009-11-20","ids":{"openalex":"https://openalex.org/W2596637202","doi":"https://doi.org/10.1182/blood.v114.22.2798.2798","mag":"2596637202"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v114.22.2798.2798","doi":"https://doi.org/10.1182/blood.v114.22.2798.2798","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v114.22.2798.2798","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053572690","display_name":"Kenneth H. Shain","orcid":"https://orcid.org/0000-0003-4178-8888","observed_orcids":["https://orcid.org/0000-0003-4178-8888"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth H Shain","raw_affiliation_strings":["Experimental Therapeutics, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069218667","display_name":"Vasco A. Oliveira","orcid":"https://orcid.org/0009-0007-1866-0022","observed_orcids":["https://orcid.org/0009-0007-1866-0022"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Vasco Oliveira","raw_affiliation_strings":["Experimental Therapeutics, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032654984","display_name":"Danielle N. Yarde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Danielle Yarde","raw_affiliation_strings":["Experimental Therapeutics, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110324556","display_name":"Linda Mathews","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda Mathews","raw_affiliation_strings":["Experimental Therapeutics, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103061547","display_name":"William S. Dalton","orcid":"https://orcid.org/0000-0001-9417-2599","observed_orcids":["https://orcid.org/0000-0001-9417-2599"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William S. Dalton","raw_affiliation_strings":["Department of Interdisciplinary Oncology and Experimental Therapeutics Program, H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Interdisciplinary Oncology and Experimental Therapeutics Program, H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa, FL, USA","institution_ids":["https://openalex.org/I2613432","https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5032654984","https://openalex.org/A5069218667"],"corresponding_institution_ids":["https://openalex.org/I3019308854"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.41938705,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"114","issue":"22","first_page":"2798","last_page":"2798"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.8457000255584717,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.8457000255584717,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.14390000700950623,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9779999852180481},{"id":"https://openalex.org/keywords/melphalan-resistance","display_name":"melphalan resistance","score":0.8199999928474426},{"id":"https://openalex.org/keywords/mesenchymal-stem-cells","display_name":"mesenchymal stem cells","score":0.9150000214576721},{"id":"https://openalex.org/keywords/rpmi-8226-cells","display_name":"RPMI 8226 cells","score":0.9049999713897705},{"id":"https://openalex.org/keywords/interstrand-crosslink-repair","display_name":"interstrand crosslink repair","score":0.8299999833106995},{"id":"https://openalex.org/keywords/fancg","display_name":"FANCG","score":0.7950000166893005},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7440000176429749},{"id":"https://openalex.org/keywords/co-culture","display_name":"co-culture","score":0.7450000047683716},{"id":"https://openalex.org/keywords/brca2","display_name":"BRCA2","score":0.39800000190734863}],"concepts":[{"id":"https://openalex.org/C2778124228","wikidata":"https://www.wikidata.org/wiki/Q845779","display_name":"Fanconi anemia","level":4,"score":0.7664860486984253},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6759202480316162},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.6079350709915161},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.603956937789917},{"id":"https://openalex.org/C2776653068","wikidata":"https://www.wikidata.org/wiki/Q17927069","display_name":"FANCD2","level":5,"score":0.5638906955718994},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5503987669944763},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.5135224461555481},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.4933842718601227},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4585745930671692},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.4037069082260132},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3325715661048889},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.267889142036438},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.2148681879043579},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1874350607395172}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v114.22.2798.2798","doi":"https://doi.org/10.1182/blood.v114.22.2798.2798","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v114.22.2798.2798","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2321607784","https://openalex.org/W1968252950","https://openalex.org/W2479413502","https://openalex.org/W2576208143","https://openalex.org/W1549949624","https://openalex.org/W6991207579","https://openalex.org/W2157720858","https://openalex.org/W2556418884","https://openalex.org/W2563013089","https://openalex.org/W1459949752"],"abstract_inverted_index":{"Abstract":[0,1],"2798":[2],"Poster":[3],"Board":[4],"II-774":[5],"Multiple":[6],"Myeloma":[7],"(MM)":[8],"is":[9,272,310],"an":[10,195,326,575],"incurable":[11],"malignancy":[12],"of":[13,21,30,35,49,72,74,88,107,145,165,207,268,293,315,339,370,380,387,423,445,481,485,515,579,646],"mature":[14],"clonal":[15],"B":[16],"cells.":[17,408,598],"The":[18,513],"refractory":[19],"nature":[20],"MM":[22,279,351,528,560,592],"has":[23,167,497],"long":[24],"been":[25,39,498],"attributed":[26],"to":[27,63,132,156,173,178,225,333,350,605,627,648],"the":[28,45,64,75,104,120,159,179,190,204,208,212,247,291,305,313,366,406,411,418,479,492,510,520,546,554,567,582,591,635],"acquisition":[29,292],"drug":[31,36,174,197,234,294,465,586],"resistance.":[32],"Traditionally,":[33],"mechanisms":[34,176,187,633],"resistance":[37,62,155,175,198,295,466,587,619],"have":[38,57],"defined":[40],"by":[41,189,274,536],"acquired":[42,154],"changes":[43,522],"in":[44,86,111,171,194,210,233,244,277,304,312,337,359,394,405,410,417,434,442,467,478,523,527,559,621,638],"expression":[46,71,106,144,220,267,299,338,384,390,404,420,526,613,637],"or":[47,361,396],"function":[48],"specific":[50,108,629],"gene":[51],"products.":[52],"To":[53],"this":[54,541],"end,":[55],"we":[56,202,258,264,288,473,504,543],"recently":[58],"demonstrated":[59,325,375,430,518],"that":[60,170,266,290,453,519,549,566],"selected":[61],"cytotoxic":[65],"agent":[66],"melphalan":[67,133,240,615],"correlated":[68],"with":[69,223,246,347,372,385,427,438,500],"increased":[70,143,150,388,443,611],"components":[73,110,271],"Fanconi":[76],"Anemia":[77],"(FA)/BRCA":[78],"DNA":[79,89,147,151,214,461,494,556,569],"repair":[80,87,148,215,462,495,557,571],"pathway":[81,218,270,382,496,558,572],"and":[82,126,153,231,239,281,330,343,391,448,463,529,561,595,600,614,632],"a":[83,139,162,376,607],"concomitant":[84],"increase":[85,336,393],"interstrand":[90],"cross-links":[91],"(ICLs).(Hazlehurst":[92],"et":[93,99],"al":[94,100],"Cancer":[95],"Res":[96],"2003;":[97],"Chen":[98],"Blood":[101],"2005)":[102],"Further,":[103],"exogenous":[105],"FANC":[109,297,402,419,612],"RPMI":[112,236,319,424],"8226":[113,237,320,425],"cell":[114,252,501,506,594,640],"lines":[115],"enhanced":[116,636],"ICL":[117],"repair,":[118,152],"favored":[119],"release":[121],"from":[122],"melphalan-induced":[123],"S-phase":[124],"delay,":[125],"rendered":[127],"these":[128,136,255],"cells":[129,238,243,280,285,352,426,429,456],"partially":[130],"resistant":[131,241],"treatment.":[134],"Together,":[135],"results":[137,257,514,564],"suggest":[138,565],"causal":[140,608],"relationship":[141,609],"between":[142,610],"FA":[146,217],"components,":[149],"melphalan.":[157],"Over":[158],"past":[160],"decade":[161],"large":[163],"body":[164],"evidence":[166],"emerged":[168],"demonstrating":[169],"addition":[172,386],"intrinsic":[177],"cancer":[180],"cell,":[181],"there":[182],"exist":[183],"dynamic,":[184],"de":[185,584],"novo":[186,585],"coordinated":[188],"tumor":[191,455,593],"microenvironment":[192,209],"resulting":[193],"environment-mediated":[196],"(EM-DR).":[199],"As":[200,491],"such,":[201],"examined":[203,401],"potential":[205,583],"role":[206],"regulating":[211],"FA/BRCA":[213,269,381,493,524,555,568],"pathway.":[216],"protein":[219,298,383,403,487,525],"was":[221],"evaluated":[222,505],"anti-sera":[224],"FANCD1/BRCA2,":[226],"FANCC,":[227,341],"FANCD2,":[228,342,446],"FANCI,":[229],"FANCG":[230,362,486],"BRCA1":[232,344],"sensitive":[235],"8226/LR5":[242],"co-culture":[245,437,489,511,622],"HS-5":[248,306,373,407,428],"bone":[249,282,469],"marrow":[250,283,470],"stromal":[251,284,597],"line.":[253],"With":[254],"preliminary":[256],"present":[259],"three":[260],"novel":[261],"findings.":[262],"First,":[263],"demonstrate":[265,544],"regulated":[273],"intracellular":[275],"interactions":[276,551],"both":[278,590,639],"(BMSCs).":[286],"Second,":[287],"show":[289],"alters":[296],"profiles":[300],"upon":[301,345],"co-culture.":[302],"Third,":[303],"BMSCs,":[307],"mono-ubiquitinated":[308,476],"FANCD2":[309,395,477],"observed":[311,475,521],"absence":[314,480],"detectable":[316,483],"FANCG.":[317],"In":[318],"cells,":[321],"Western":[322],"blot":[323],"analysis":[324,517],"acute":[327],"(within":[328],"30minutes)":[329],"prolonged":[331],"(up":[332],"48hours)":[334],"time-dependent":[335],"FANCD2/BRCA2,":[340],"incubation":[346],"BMSCs":[348,374,412],"relative":[349],"incubated":[353],"alone.":[354],"However,":[355],"no":[356,392],"appreciated":[357],"increases":[358],"FANCI":[360,389,447],"were":[363,415],"noted":[364,416],"under":[365,488,509],"same":[367],"conditions.":[368,490,512],"Incubation":[369],"8226/LR5s":[371,440],"slightly":[377],"different":[378,454],"up-regulation":[379],"FANCC":[397],"expression.":[398],"We":[399],"also":[400,474],"Interestingly,":[409],"significant":[413],"differences":[414],"profiles.":[421],"Co-culture":[422],"only":[431],"modest":[432],"elevations":[433],"FANCD2;":[435],"however,":[436],"drug-resistant":[439],"resulted":[441],"levels":[444,484],"BRCA1.":[449],"These":[450,563],"data":[451],"indicate":[452],"may":[457,573],"alternately":[458],"influence":[459],"FA/BRCA-mediated":[460],"potentially":[464],"juxtaposed":[468],"stroma.":[471],"Curiously,":[472],"any":[482],"associated":[499],"cycle":[502,507],"progression,":[503],"kinetics":[508],"BrdU":[516],"BMSC":[530],"could":[531],"not":[532],"be":[533,574],"fully":[534],"explained":[535],"cell-cycle":[537],"distribution.":[538],"Therefore,":[539],"within":[540],"report":[542],"for":[545],"first":[547],"time":[548],"microenvironmental":[550],"can":[552],"modulate":[553],"BMSCs.":[562],"damage":[570],"important":[576],"modulatory":[577],"component":[578],"EM-DR.":[580],"Importantly,":[581],"likely":[588],"involves":[589],"adjacent":[596],"Current":[599],"future":[601],"studies":[602],"will":[603],"attempt":[604],"examine":[606],"(and":[616],"other":[617],"drug)":[618],"seen":[620],"conditions,":[623],"as":[624,626],"well":[625],"identify":[628],"signaling":[630],"molecules":[631],"controlling":[634],"models.":[641],"Disclosures:":[642],"No":[643],"relevant":[644],"conflicts":[645],"interest":[647],"declare.":[649]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2017-03-23T00:00:00"}